















































concentrated Ascites Reinfusion Therapy : CART）を施行していたが，施行中の膜圧上昇による処理困難症例や長時
間処理，施行後の副作用などが問題となっていた．そこで外圧濾過方式の腹水濾過濃縮再静注法（Keisuke Matsusaki







































































表3 肝性腹水に対する CARTと KM-CARTの比較








表4 癌性腹水に対する CARTと KM-CARTの比較
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Current Practice of Cell-free and Concentrated Ascites Reinfusion
Therapy at Our Hospital
Terumi TSUJINO, Kayoko IMAMURA, Yu TAKEOKA, Hiroaki NAGATA
Division of Clinical Engineering Technology, Tokushima Red Cross Hospital
At our hospital, cell-free and concentrated ascites reinfusion therapy（CART）using the internal pressure filtra-
tion method has been applied to treat refractory ascites in patients with carcinomatous peritonitis, hepatic cirr-
hosis, etc. However, issues associated with this therapy are, among others, procedural difficulties due to increas-
ed film pressure during a therapy session, prolonged procedural times, and postprocedural adverse reactions.
Thus, Keisuke Matsusaki cell-free and concentrated ascites reinfusion therapy（KM-CART）using the external pre-
ssure filtration method was introduced in November2017.
In this study,49 CART sessions and51 KM-CART sessions performed between April2016 and July2018were
compared retrospectively for the volume of processed ascites, procedural time, incidence of adverse reactions, etc.
Compared to CART, KM-CART was simpler in terms of circuit construction and operability, and all ascites
could be processed by KM-CART. In addition, procedural times for KM-CART were shorter, there was decreas-
ed fever after application of the therapy, and oral intake improved.
The results of this study indicate that KM-CART is useful for improving the quality of life of patients.
Key words : Keisuke Matsusaki cell-free and concentrated ascites reinfusion therapy（KM-CART）, refractory as-
cites, quality of life（QOL）
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